Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
72.1M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
34M
-
Shares change
-
+447K
-
Total reported value, excl. options
-
$109M
-
Value change
-
+$1.31M
-
Put/Call ratio
-
0
-
Number of buys
-
23
-
Number of sells
-
-35
-
Price
-
$3.21
Significant Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q4 2021
82 filings reported holding OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share as of Q4 2021.
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34M shares
of 72.1M outstanding shares and own 47.18% of the company stock.
Largest 10 shareholders include BVF INC/IL (6.63M shares), EcoR1 Capital, LLC (6.08M shares), Stonepine Capital Management, LLC (4.01M shares), VANGUARD GROUP INC (3.44M shares), Artal Group S.A. (2.5M shares), ACADIAN ASSET MANAGEMENT LLC (2.04M shares), GLOBEFLEX CAPITAL L P (1.4M shares), BlackRock Inc. (1.15M shares), PLATINUM INVESTMENT MANAGEMENT LTD (767K shares), and D. E. Shaw & Co., Inc. (759K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.